Pangaea Oncology SA (PANG) Stock Price & News

All values in EUR	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Revenue	4.17M	4.17M	4.19M	4.19M
Cost of goods sold	642.93K	642.93K	648.84K	648.84K
Cost of revenue	642.93K	642.93K	648.84K	648.84K
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3.69M	3.69M	3.94M	3.94M
Operating expense	4.38M	4.38M	4.64M	4.64M
Total operating expenses	5.02M	5.02M	5.29M	5.29M
Operating income	-851.91K	-851.91K	-1.09M	-1.09M
Other non operating income	28.82K	28.82K	48.23K	48.23K
EBT including unusual items	-860.55K	-860.55K	-1.15M	-1.15M
EBT excluding unusual items	-860.55K	-860.55K	-1.15M	-1.15M
Income tax expense	-54.22K	-54.22K	-173.94K	-173.94K
Effective tax rate	6.30%	6.30%	15.10%	15.10%
Other operating expenses	3.71K	3.71K	-658.00	-658.00
Net income	-846.30K	-846.30K	-951.76K	-951.76K
Net profit margin	-20.28%	-20.28%	-22.69%	-22.69%
Earnings per share	-	-	-	-
Interest and investment income	583.00	583.00	-	-
Interest expense	-51.44K	-51.44K	-97.69K	-97.69K
Net interest expenses	-50.86K	-50.86K	-97.69K	-97.69K
Depreciation and amortization charges	689.26K	689.26K	700.90K	700.90K
EBITDA	-521.46K	-521.46K	-779.73K	-779.73K
Gain or loss from assets sale	-	-	-	-

AI content may include mistakes. Learn more

Finance